MediPharm Labs Corp. (MEDIF)
MEDIF Stock Price Chart
Explore MediPharm Labs Corp. interactive price chart. Choose custom timeframes to analyze MEDIF price movements and trends.
MEDIF Company Profile
Discover essential business fundamentals and corporate details for MediPharm Labs Corp. (MEDIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2021
Employees
166.00
Website
https://www.medipharmlabs.comCEO
David A. Pidduck
Description
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
MEDIF Financial Timeline
Browse a chronological timeline of MediPharm Labs Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.01 falling short of the estimated -$0.00 by -505.45%, while revenue for the quarter reached $8.67M , beating expectations by +7.21%.
Earnings released on 14 May 2025
EPS came in at -$0.00 , while revenue for the quarter reached $7.59M .
Earnings released on 27 Mar 2025
EPS came in at -$0.00 , while revenue for the quarter reached $8.37M .
Earnings released on 14 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $7.22M .
Earnings released on 14 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $7.57M .
Earnings released on 15 May 2024
EPS came in at -$0.01 falling short of the estimated -$0.01 by -10.20%, while revenue for the quarter reached $7.20M , beating expectations by +3.24%.
Earnings released on 27 Mar 2024
EPS came in at -$0.01 surpassing the estimated -$0.01 by +15.24%, while revenue for the quarter reached $6.87M , beating expectations by +5.16%.
Earnings released on 14 Nov 2023
EPS came in at -$0.01 falling short of the estimated -$0.00 by -157.34%, while revenue for the quarter reached $6.28M , missing expectations by -17.71%.
Earnings released on 14 Aug 2023
EPS came in at -$0.01 surpassing the estimated -$0.01 by +53.91%, while revenue for the quarter reached $7.23M , missing expectations by -28.95%.
Earnings released on 31 Mar 2023
EPS came in at -$0.02 falling short of the estimated -$0.02 by -33.33%, while revenue for the quarter reached $4.32M , missing expectations by -5.81%.
Earnings released on 27 Mar 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -20.41%, while revenue for the quarter reached $4.19M , missing expectations by -2.72%.
Earnings released on 14 Nov 2022
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $5.30M , beating expectations by +48.82%.
Earnings released on 15 Aug 2022
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $3.39M , missing expectations by -19.30%.
Earnings released on 16 May 2022
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $3.90M , missing expectations by -18.91%.
Earnings released on 31 Mar 2022
EPS came in at -$0.08 falling short of the estimated -$0.02 by -300.00%, while revenue for the quarter reached $17.03M , beating expectations by +263.58%.
Earnings released on 15 Nov 2021
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $4.26M .
Earnings released on 16 Aug 2021
EPS came in at -$0.05 falling short of the estimated -$0.03 by -66.67%, while revenue for the quarter reached $4.09M .
Earnings released on 17 May 2021
EPS came in at -$0.07 falling short of the estimated -$0.03 by -133.33%, while revenue for the quarter reached $4.37M .
Earnings released on 31 Mar 2021
EPS came in at -$0.21 falling short of the estimated -$0.03 by -600.00%, while revenue for the quarter reached $28.21M .
Earnings released on 16 Nov 2020
EPS came in at -$0.11 falling short of the estimated -$0.03 by -266.67%, while revenue for the quarter reached $3.72M .
MEDIF Stock Performance
Access detailed MEDIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.